Unique ID issued by UMIN | UMIN000043944 |
---|---|
Receipt number | R000050146 |
Scientific Title | Evaluation of the efficacy of Lactobacillus lubricant gel as a feminine care product |
Date of disclosure of the study information | 2021/04/16 |
Last modified on | 2023/04/18 11:05:17 |
Evaluation of the efficacy of Lactobacillus lubricant gel as a feminine care product
Evaluation of the efficacy of Lactobacillus lubricant gel as a feminine care product
Evaluation of the efficacy of Lactobacillus lubricant gel as a feminine care product
Evaluation of the efficacy of Lactobacillus lubricant gel as a feminine care product
Japan |
Healthy subjects
Adult |
Others
NO
To evaluate the efficacy of Lactobacillus containing lubricant gel as a feminine care product
Safety
Confirmatory
Explanatory
Not applicable
Changes in vaginal flora types, compositions, diversity index and clusters before and after the intervention at 4 weeks
Comparison of the following changes before and after the intervention at 4 weeks
2. Vaginal pH
3. Lifestyle habits, well being, climacteric symptoms, overactive bladder symptoms
One time evaluation before the intervention
4. Vaginal maturation index
5. Ovarian function(E2, FSH)
6. Gut micro-flora
7. Equol producer status
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
6
Treatment
Other |
Five pre-menopausal women without using any feminine products
Fifteen pre-menopausal women using feminine soap and cream for 4 weeks
Fifteen pre-menopausal women using feminine soap, cream and Lactobacillus containing lubricant gel for 4 weeks
Five post-menopausal women without using any feminine products
Fifteen postmenopausal women using feminine soap and cream for 4 weeks
Fifteen postmenopausal women using feminine soap, cream and Lactobacillus containing lubricant gel for 4 weeks
20 | years-old | <= |
75 | years-old | >= |
Female
Thirty five healthy pre-menopausal women (20-49 years of age)
Thirty five healthy postmenopausal women (50-75 years of age)
-Who give consent on the research
-Postmenopausal women (natural absence of menstruation over at least 12 months since the last menstrual period or FSH >= 25mIU/mL, E2<20pg/mL excluding surgical menopause
1. Those under treatment for urinary tract infection
2. Those under treatment for urinary stone, hydronephrosis, renal tumor, etc.
3. Those who have taken antibiotics or steroids 2 weeks before the study or during the study
4. Those who have skin lesions on skin and mucosa of external genitalia or gynecological diseases such as vaginitis (except from asymptomatic atrophic vaginitis)
5. Those considered ineligible by the investigators
70
1st name | Remi |
Middle name | |
Last name | Yoshikata |
Shinkokai Medical Corporation
Hamamatsucho Hamasite Clinic
102-0022
Shiodome Building 2F, 1-2-20 Kaigan, Minato-ku, Tokyo
03-5472-1100
r-yoshikata@tokyomidtown-mc.jp
1st name | Shoji |
Middle name | |
Last name | Isono |
Advanced Medical Care Co. Ltd.
Aging Care Division
106-0032
Engyo Building 7F, 7-15-14 Roppongi, Minato-ku, Tokyo
03-6890-0036
s-isono@amcare.co.jp
Aging Care Division
Advanced Medical Care Co. Ltd.
Aging Care Division
Advanced Medical Care Co. Ltd.
Profit organization
Japan
Hamamatsucho Hamasite Clinic
Shinkokai Medical Corporation
Institutional Review Board of the Medical Corporation of Shinkokai
SVAX Nishi-Shinbashi Building, 2-39-3 Nishi-Shinbashi, Minato-ku, Tokyo
03-5408-8690
chie-nishijima@shinkokai.co.jp
NO
2021 | Year | 04 | Month | 16 | Day |
https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000050146
Published
https://doi.org/10.1371/journal.pone.0270242
70
Vaginal pH and pathogenic flora were reduced in both treatment groups compared to control group,especially in the treatment 2 group of postmenopausal women. Genitourinary symptoms significantly improved in 60% of premenopausal women in treatment 1 group and 81.3% of postmenopausal women in treatment 2 group compared to control group. Overactive bladder symptom scores were significantly improved in postmenopausal women suspected of having overactive bladder.
2022 | Year | 04 | Month | 18 | Day |
2022 | Year | 12 | Month | 30 | Day |
70 healthy Japanese women, who volunteered to participate in the study conducted at the Hamasite Clinic in Tokyo Prefecture from April to July 2021. Half of them were premenopausal women, and half were postmenopausal women. Menopause was defined as no menstruation at least 12 months since the last menstrual period, follicular stimulating hormone level of 25mIU/mL and above and estradiol level less than 20 pg/ml.
The recruitment process started in March 2021, using pamphlets and posters targeting the female employees at the Resorttrust, Inc., their relatives and friends. The contents include the importance of feminine care, the objectives of the study, inclusion and exclusion criteria, measurements, tests and products to be used, study period, incentive for participation, and contact details. Within one month of recruitment, seventy-three women registered for participation in the study. Among them, 70 were selected based on the inclusion and exclusion criteria by the end of March, 2021.
No adverse events reported.
Comparison of the changes in the vaginal microbiota, genitourinary symptoms, and other related biomarkers before and after completion of treatment.
Completed
2021 | Year | 03 | Month | 23 | Day |
2021 | Year | 03 | Month | 22 | Day |
2021 | Year | 05 | Month | 01 | Day |
2021 | Year | 07 | Month | 01 | Day |
2021 | Year | 08 | Month | 31 | Day |
2021 | Year | 09 | Month | 30 | Day |
2021 | Year | 10 | Month | 31 | Day |
2021 | Year | 04 | Month | 16 | Day |
2023 | Year | 04 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050146
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |